Skip to content
  • YouTube
  • Facebook
  • LinkedIn
Pharm'Up

Pharm'Up

An E-platform for Learners

https://www.youtube.com/watch?v=xuTKPPZrxy4
Primary Menu
  • Home
  • News
  • Industries
  • Disease
  • Drugs
  • Events
  • Jobs
  • Trainings
  • Conferences
  • Syllabus
  • Previous Papers
  • Notes
  • Colleges
Live
  • Home
  • 2025
  • August
  • 22
  • Study Finds “Good Cholesterol” May Reduce Risk of Stress Urinary Incontinence
  • Pharma News

Study Finds “Good Cholesterol” May Reduce Risk of Stress Urinary Incontinence

Pharm'Up 2 min read

A recent study published in the International Journal of Medical Sciences has uncovered a compelling link between elevated levels of high-density lipoprotein cholesterol (HDL-C)—commonly known as “good cholesterol”—and a reduced risk of developing stress urinary incontinence (SUI). This protective effect was found to be particularly strong in women who are overweight or have obesity. These findings introduce metabolic health as a new and potentially crucial area for SUI prevention research.

The Study’s Methodology and Findings

To explore the relationship between HDL-C and SUI, the researchers conducted a two-part study. They first analyzed cross-sectional data from the National Health and Nutrition Examination Survey (NHANES), which included over 18,000 women. They then used a two-sample Mendelian randomization approach to investigate a potential causal link. This dual-evidence approach strengthened the reliability of their conclusions.

The findings were robust and consistent:

  • A Protective Effect: For every 1 mg/dL increase in a woman’s HDL-C level, the risk of SUI decreased by 0.8%.
  • A Key Threshold: Women with an HDL-C level of 67 mg/dL or more had a significantly reduced risk of SUI (17.3% lower) compared to those with lower levels.
  • Greater Benefit for Higher BMI: The protective effect of HDL-C was most pronounced in individuals with overweight (BMI ≥ 25 kg/m$^2$) or obesity (BMI ≥ 30 kg/m$^2$), suggesting that metabolic health may be particularly important for SUI prevention in these high-risk populations.
  • SUI Frequency Reduction: The study also found that higher HDL-C levels were associated with a parallel decrease in the frequency of SUI episodes.

Implications and Future Directions

While the study suggests a causal relationship, the authors noted a non-linear “HDL-C paradox” in some of their analyses, indicating that the relationship is not simple and requires further investigation. This highlights the complexity of metabolic health and its impact on conditions like SUI.

However, the findings from this large, nationally representative study provide a solid foundation for future research. The authors conclude that maintaining optimal HDL-C levels may offer a valuable preventive strategy against SUI. Future studies will need to delve into the specific biological mechanisms by which HDL-C influences urinary incontinence and validate these associations across diverse demographic groups. These insights could lead to new clinical guidelines or therapeutic interventions that leverage metabolic health to prevent a common and debilitating condition in women.

About the Author

Pharm'Up

Author

An E-platform for Pharma Learners

View All Posts

Post navigation

Previous: August 2025 Product News: FDA Approvals Drive Progress in Shingles, Diabetes, and Heart Health
Next: Orforglipron New Oral GLP-1 Therapy Shows Promise for Weight Management

Related Stories

Pharmup 4
2 min read
  • Pharma News

Future-Proofing Pharmacy: Saveetha College Webinar Explores the AI and IT Revolution

Pharm'Up
Pharmup 3
2 min read
  • Pharma News

Global Power Move: Sun Pharma’s $11.75 Billion Acquisition of Organon

Pharm'Up
Pharmup 2
2 min read
  • Pharma News

The Science of the “Super-Brush”: How Graphene Kills Bacteria Without Harming Humans

Pharm'Up

Recent Posts

  • Navigating Balance Disorders: Causes, Symptoms, and Management
  • Understanding Seasonal Allergic Rhinitis: Causes, Symptoms, and Relief
  • Pharmacovigilance Specialist Opportunity at Bausch + Lomb
  • Career Opportunity: Formulation & Development (Injectable) at Derren Healthcare
  • Sun Pharma Recruitment: Manager – EU Compliance (Tandalja R&D)

Recent Comments

No comments to show.

Archives

  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025

Categories

  • Colleges
  • Conferences/ Workshops
  • Disease
  • Drugs
  • Events
  • Industries
  • Notes
  • Pharma Jobs
  • Pharma News
  • Previous Papers
  • Syllabus
  • Trainings/ Courses
  • Uncategorized

Read These Too

Pharmup 21
2 min read
  • Disease

Navigating Balance Disorders: Causes, Symptoms, and Management

Pharm'Up
Pharmup 20
1 min read
  • Disease

Understanding Seasonal Allergic Rhinitis: Causes, Symptoms, and Relief

Pharm'Up
Pharmup 19
1 min read
  • Pharma Jobs

Pharmacovigilance Specialist Opportunity at Bausch + Lomb

Pharm'Up
Pharmup 18
1 min read
  • Pharma Jobs

Career Opportunity: Formulation & Development (Injectable) at Derren Healthcare

Pharm'Up
  • YouTube
  • Facebook
  • LinkedIn
Copyright ©Pharm'UP All rights reserved by Eduversity India | MoreNews by AF themes.